1. Home
  2. SPOK vs PROF Comparison

SPOK vs PROF Comparison

Compare SPOK & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

SELL

Current Price

$10.83

Market Cap

218.8M

ML Signal

SELL

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.13

Market Cap

248.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPOK
PROF
Founded
2004
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.8M
248.8M
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
SPOK
PROF
Price
$10.83
$6.13
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $11.14
AVG Volume (30 Days)
114.4K
★ 260.9K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 11.65%
N/A
EPS Growth
2.74
★ 25.89
EPS
★ 0.29
N/A
Revenue
★ $139,708,000.00
$16,098,000.00
Revenue This Year
N/A
$71.10
Revenue Next Year
N/A
$58.54
P/E Ratio
$37.00
★ N/A
Revenue Growth
1.49
★ 50.73
52 Week Low
$9.95
$4.91
52 Week High
$16.45
$8.95

Technical Indicators

Market Signals
Indicator
SPOK
PROF
Relative Strength Index (RSI) 53.25 47.49
Support Level $10.28 $5.74
Resistance Level $10.87 $6.23
Average True Range (ATR) 0.19 0.42
MACD 0.00 0.06
Stochastic Oscillator 61.64 30.29

Price Performance

Historical Comparison
SPOK
PROF

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: